K2 PRINCIPAL FUND, L.P. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 63 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$442,000
-24.8%
58,772
+23.8%
0.05%0.0%
Q1 2022$588,000
-67.5%
47,462
-66.0%
0.05%
-66.0%
Q2 2021$1,808,000
+12.2%
139,499
+25.7%
0.15%
-50.8%
Q1 2020$1,611,000
-28.4%
111,0000.0%0.30%
+56.4%
Q4 2019$2,249,000
+4064.8%
111,000
+825.0%
0.20%
+4775.0%
Q4 2017$54,000
-76.6%
12,000
-67.5%
0.00%
-73.3%
Q3 2017$231,000
-45.4%
36,900
-81.7%
0.02%
-62.5%
Q4 2016$423,000201,5220.04%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders